Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date | Article Title |
Journal |
|---|---|---|---|
|
Teemu D. Laajala, Mika Murtojārvi, Arho Virkki, Tero Aittokalio |
June 2018 | ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts | Bioinformatics |
|
Thierry Wendling, Hitesh Mistry, Kayode Ogungbenro, Leon Aarons |
March 2016 | Predicting Survival of Pancreatic Cancer Patients Treated with Gemcitabine Using Longitudinal Tumour Size Data | Cancer Chemotherapy and Pharmacology |
|
Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates |
April 2019 | Resistance Models to EGFR Inhibition and Chemotherapy in Non-Small Cell Lung Cancer Via Analysis of Tumour Size Dynamics | Cancer Chemotherapy and Pharmacology |
|
H-G Eichler, B Bloechl-Daum, P Bauer, F Bretz, J Brown, LV Hampson, P Honig, M Krams, H Leufkens, R Lim, MM Lumpkin, MJ Murphy, F Pignatti, M Posch, S Schneeweiss, M Trusheim, F Koenig |
September 2016 | “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? | Clinical Pharmacology & Therapeutics |
|
Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh |
June 2016 | Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel | European Urology |
|
Daniel E. Spratt, Yu-Wei Chen, Brandon A. Mahal, Joseph R. Osborne, Shuang G. Zhao, Todd M. Morgan, Ganesh Palapattu, Felix Y. Feng, Paul L. Nguyen |
March 2016 | Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes | European Urology |
|
Stephen B. Cohen, Jennifer Unangst |
September 2018 | Data Integration Innovations to Enhance Analytic Utility of Clinical Trial Content to Inform Health Disparities Research | Frontiers in Oncology |
|
Fatemeh Seyednasrollah, Devin C. Koestler, Tao Wang, Stephen R. Piccolo, Roberto Vega, Russell Greiner, Christiane Fuchs, Eyal Gofer, Luke Kumar, Russell D. Wolfinger, Kimberly Kanigel Winner, Chris Bare, Elias Chaibub Neto, Thomas Yu, Liji Shen, Kald Abdallah, Thea Norman, Gustavo Stolovitzky, Howard R. Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Laura L. Elo, Fang Liz Zhou, Justin Guinney, James C. Costello, and Prostate Cancer DREAM Challenge Community |
August 2017 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer | Journal of Clinical Oncology |
|
Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy |
June 2018 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
|
Anish B. Parikh, Alberto Martini, John Sfakianos, Matt D. Galsky, William K. Oh, Che-Kai Tsao |
February 2020 | Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data | Journal of Clinical Oncology |
|
Charles Hugh-Jones, Robin Jenkins, Joel Beetsch, Kald Abdallah, Michael Curnyn, Fang Liz Zhou, Mace L. Rothenberg, Gregory A. Curt, John Dornan, Martin J. Murphy |
January 2017 | Overcoming barriers to develop a broad access data sharing platform | Journal of Clinical Oncology |
|
Ketan Patel, Mario Ouwens, Norah Shire, Sajan Khosla |
May 2017 | The application of electronic medical records (EMRs) as a virtual comparator arm in a lung cancer clinical trial: A case study | Journal of Clinical Oncology |
|
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo |
January 2017 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis | The Lancet Oncology |
|
Justin Guinney, Tao Wang, Teemu D. Laajala, Kimberly Kanigel Winner, J. Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahkkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Yang Xie, Tero Aittokallio, Fang Liz Zhou, James C. Costello |
January 2017 | Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data | The Lancet Oncology |
